搜尋
Arrivent Biopharma Inc
AVBP添加自選
31.740USD
+0.380+1.21%
收盤 06/18, 16:00（美東）報價延遲15分鐘
1.48B總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
INFINITUM ASSET MANAGEMENT, LLC
8.85%
Suvretta Capital Management, LLC
8.82%
HHLR Advisors, Ltd.
8.44%
Fidelity Management & Research Company LLC
7.95%
OrbiMed Advisors, LLC
6.50%
其他
59.44%
持股股東
持股股東
佔比
INFINITUM ASSET MANAGEMENT, LLC
8.85%
Suvretta Capital Management, LLC
8.82%
HHLR Advisors, Ltd.
8.44%
Fidelity Management & Research Company LLC
7.95%
OrbiMed Advisors, LLC
6.50%
其他
59.44%
股東類型
持股股東
佔比
Investment Advisor
36.78%
Hedge Fund
18.92%
Investment Advisor/Hedge Fund
15.68%
Venture Capital
11.13%
Private Equity
6.53%
Individual Investor
2.78%
Research Firm
2.23%
Bank and Trust
0.20%
Pension Fund
0.07%
其他
5.67%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
236
42.29M
91.21%
+921.79K
2025Q4
203
40.51M
86.20%
+2.23M
2025Q3
200
38.29M
87.13%
+4.89M
2025Q2
183
33.29M
86.81%
+2.78M
2025Q1
161
29.16M
89.66%
-1.36M
2024Q4
146
28.54M
81.09%
+2.38M
2024Q3
112
25.96M
67.99%
+4.20M
2024Q2
92
21.76M
65.52%
-193.40K
2024Q1
72
21.95M
14.98%
+16.93M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
INFINITUM ASSET MANAGEMENT, LLC
4.12M
9.33%
+255.00K
+6.59%
Dec 31, 2025
Suvretta Capital Management, LLC
4.11M
9.29%
+402.58K
+10.87%
Dec 31, 2025
HHLR Advisors, Ltd.
3.93M
8.89%
-555.55K
-12.39%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.70M
8.38%
+296.02K
+8.69%
Dec 31, 2025
OrbiMed Advisors, LLC
3.03M
6.85%
--
--
Dec 31, 2025
HBM Partners AG
2.20M
4.97%
+2.20M
--
Oct 08, 2025
BlackRock Institutional Trust Company, N.A.
2.12M
4.8%
+272.94K
+14.77%
Dec 31, 2025
Octagon Capital Advisors LP
1.97M
4.46%
--
--
Dec 31, 2025
Novo Holdings A/S
1.94M
4.39%
--
--
Dec 31, 2025
Sofinnova Investments, Inc
1.70M
3.84%
--
--
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
0.54%
State Street SPDR S&P Biotech ETF
0.16%
ProShares Ultra Nasdaq Biotechnology
0.11%
Direxion Daily S&P Biotech Bull 3X Shares
0.1%
iShares Micro-Cap ETF
0.09%
Invesco Nasdaq Biotechnology ETF
0.07%
iShares Biotechnology ETF
0.05%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.05%
iShares Russell 2000 Growth ETF
0.03%
Global X Russell 2000 ETF
0.02%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
佔比0.54%
State Street SPDR S&P Biotech ETF
佔比0.16%
ProShares Ultra Nasdaq Biotechnology
佔比0.11%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.1%
iShares Micro-Cap ETF
佔比0.09%
Invesco Nasdaq Biotechnology ETF
佔比0.07%
iShares Biotechnology ETF
佔比0.05%
iShares MSCI USA Small-Cap Min Vol Factor ETF
佔比0.05%
iShares Russell 2000 Growth ETF
佔比0.03%
Global X Russell 2000 ETF
佔比0.02%
